Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Long-term outcomes and risk modifiers of metabolic dysfunction-associated steatotic liver disease between lean and non-lean populations

Pojsakorn Danpanichkul, Kanokphong Suparan, Vitchapong Prasitsumrit, Aijaz Ahmed, Karn Wijarnpreecha, Donghee Kim

Clin Mol Hepatol. 2025;31(1):74-89. Published online October 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0631

View: 3000 Download: 351 Web of Science: 5 Crossref: 7

Original Article

Global Epidemiology of Alcohol-Related Liver Disease, Liver Cancer, and Alcohol Use Disorder, 2000–2021

Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, Primrose Tothanarungroj, Supapitch Sirimangklanurak, Thanida Auttapracha, Hanna L. Blaney, Banthoon Sukphutanan, Yanfang Pang, Siwanart Kongarin, Francisco Idalsoaga, Eduardo Fuentes-López, Lorenzo Leggio, Mazen Noureddin, Trenton M. White, Alexandre Louvet, Philippe Mathurin, Rohit Loomba, Patrick S. Kamath, Jürgen Rehm, Jeffrey V. Lazarus, Karn Wijarnpreecha, Juan Pablo Arab

Received September 26, 2024 Accepted January 3, 2025

DOI: https://doi.org/10.3350/cmh.2024.0835 [Accepted]

View: 2052 Download: 193 Crossref: 3

Correspondence

Correspondence to “Burden of alcohol use disorder, alcohol-related liver disease, and alcohol-related liver cancer”

Pojsakorn Danpanichkul, Luis Antonio Diaz, Kanokphong Suparan, Karn Wijarnpreecha, Juan Pablo Arab

Received February 11, 2025 Accepted February 14, 2025

DOI: https://doi.org/10.3350/cmh.2025.0166 [Accepted]

View: 336 Download: 21

1 |

Viewed By 7362	MAFLD: How is it different from NAFLD?
Viewed By 6913	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 5569	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5339	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4765	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 298	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 270	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 93	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search